Insilico Medicine and CMS expand AI collaboration on CNS diseases
July 13, 2026 | 11:35
Insilico Medicine and China Medical System Holdings announced additional collaborations in central nervous system diseases, deepening their AI-powered drug research partnership between the two Hong Kong-listed healthcare companies.
Mobile Version